2011
DOI: 10.1016/j.cct.2011.06.004
|View full text |Cite
|
Sign up to set email alerts
|

Application of latent growth and growth mixture modeling to identify and characterize differential responders to treatment for COPD

Abstract: Patients with COPD represent a heterogeneous population in terms of their reporting of symptoms and response to treatment. GMM analyses are able to identify sub-groups of responders and non-responders. Application of this methodology could be of value on other endpoints in COPD and in other disease areas.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
32
0

Year Published

2012
2012
2021
2021

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 25 publications
(33 citation statements)
references
References 26 publications
1
32
0
Order By: Relevance
“…As heterogeneity in response to treatment is common in clinical trials, 39,40 we further sought to identify homogenous subgroups of patients who respond differently to the intervention.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…As heterogeneity in response to treatment is common in clinical trials, 39,40 we further sought to identify homogenous subgroups of patients who respond differently to the intervention.…”
Section: Discussionmentioning
confidence: 99%
“…Trends in change in BP during the course of the 8‐week intervention period were examined by means of latent class growth modeling (LCGM) using Mplus version 7.1 (Muthén & Muthén, 1998–2010, Los Angeles, CA). As heterogeneity in response to treatment is common in clinical trials, we further sought to identify homogenous subgroups of patients who respond differently to the intervention.…”
Section: Methodsmentioning
confidence: 99%
“…Despite these efforts, differential treatment response can still exist; that is, not all patients in treatment groups respond in the same way or to the same extent. This can disguise true treatment effects and potentially mask the value of products for particular patients by increasing the mean response where there is a class of hyperresponders or, conversely, decreasing the mean response where there is a class of hypo-or nonresponders [5]. That is, some patients in active treatment groups may show no response, or deterioration, and when their results are analyzed together with the results of responsive patients, the overall treatment effect is dampened.…”
Section: Introductionmentioning
confidence: 99%
“…However, as discussed above, this assumption may be untenable in some circumstances for any number of reasons (e.g., different genotypes, differences in health care use outside the trial protocol, differences in concomitant medication use, and differences in family or social support). Differences between individuals can result in qualitatively and quantitatively different slopes of change over time [4,5].…”
Section: Introductionmentioning
confidence: 99%
“…Therefore, there are two types of HTE: 1) the latent class variable in GMM divides individuals into groups with different growth curves; and 2) coefficient estimates vary across latent classes. Donald Stull et al apply GMM to identify and characterize differential responders to treatment for COPD [44]. In comparison of LGM and GMM focusing on longitudinal data, Luke & Muthen discuss factor mixture modeling as a method for cross-sectional studies when heterogeneous populations arise in a similar fashion as in GMM [45].…”
Section: Reviewmentioning
confidence: 99%